All News

MELBOURNE, Australia -- A fracture risk score for osteoporotic women may help clinicians decide how to proceed when multiple-site bone mineral density measurements disagree, researchers said.

ROCKVILLE, Md. -- The FDA has alerted physicians to a new label warning for the anti-angiogenic colorectal-cancer drug Avastin (bevacizumab) that cites rare cases of a reversible posterior leukoencephalopathy syndrome.

SAN FRANCISCO -- Smokers whose preferred puff is menthol-flavored may find it harder to quit, and the cool-tasting cigarettes are just as bad for the arteries and lungs as non-menthol brands, but no worse, found a long-running cohort story here.

TORONTO -- More than two-thirds of gastric cancer patients received inadequate lymph node assessment, jeopardizing their treatment and survival, researchers reported after an analysis of data on nearly 11,000 cases.

WASHINGTON -- The Institute of Medicine has taken the FDA to the woodshed with a scathing report issued today that found the agency had lost credibility in its regulation of the pharmaceutical industry.

LIVERPOOL, England -- Throwing a raw egg is a prank gone bad all too often, warned emergency physicians here who cited blunt ocular trauma.

RESEARCH TRIANGLE PARK, N.C. -- More aggressive management of pregnancies with preeclampsia has appeared to have a big payoff in terms of fetal survival.

BOSTON -- A form of niacin may be a novel treatment for chronic progressive multiple sclerosis, according to researchers here. In a mouse model of MS, nicotinamide- the amide form of niacin, or vitamin B3 - significantly prevented disability.

ANN ARBOR, Mich. -- Despite better detection and more curative surgery, kidney cancer mortality rates continue to rise - a "treatment disconnect" that raises thorny questions.